Vancouver, British Columbia, April 6, 2021 – Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company”) (CSE: DOCT, Frankfurt: 7FM4) is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. (“Micron Technologies”).
Manufacturing Three-Ply Medical Grade Face Masks at Full Capacity
Micron Technologies has been manufacturing and selling three-ply medical grade face masks at the Company’s facility in Delta, British Columbia since August 2020. The three-ply medical grade face masks are being manufactured pursuant to Micron Technologies’ Medical Device Establishment License issued by Health Canada. The three-ply medical grade face masks offer three layers of protection, which conforms to the American Society for Testing and Materials’ F2100 Level 3 standards. The non-woven masks feature an adjustable nose clip designed to protect both front-line workers and consumers. Micron Technologies is currently operating three shifts a day to manufacture three-ply medical grade face masks.
Manufacturing N95 Face Masks
Micron Technologies is now also setting up manufacturing N95 Model 8800 face masks, which have been approved. Micron Technologies has submitted its N95 Model 8800 face masks to the National Institute for Occupational Safety and Health (“NIOSH”) and is confident it will obtain NIOSH certification as its N95 Model 8800 face masks have already passed testing with Kinetrics Analytical and Environmental Laboratories. Micron Technologies has purchased a large quantity of raw materials to manufacture N95 Model 8800 face masks and plans to maximize production efforts once NIOSH certification has been obtained. As of last month there was still a significant shortage of N95 masks and approximately“56 percent of frontline workers say they still don’t have enough N95 masks”.
Third Wave of COVID-19
According to Dr. Abdu Sharkawy, an infectious disease specialist, the third wave of COVID-19 is “likely going to be worse than the first two.” With respect to the addition of variants, Dr. Sharkawy noted “and of course we’ve seen what these=variants can offer, they can really lead to an explosion of cases very quickly.” Dr. Theresa Tam, Canada’s Chief Public Health Officer, announced a 64% increase in new cases involving variants. In addition to the new variants,the slow vaccine roll-out and complacency with public health restrictions are contributing to the third wave.
Earlier this month Canada surpassed 1,000,000 confirmed COVID-19 cases since the beginning of the pandemic, with the provinces of Ontario, Quebec, and British Columbia being hit the hardest by the third wave.
Products Now Available at Walmart
As previously announced, Micron Technologies’ three-ply medical grade face masks and N95 medical grade face masks have been approved for sale by Walmart. Micron Technologies expects its products to be available at www.walmart.com in the coming weeks.
In addition to Walmart, Micron Technologies’ products are also available on Amazon and Shopify. Institutional customers and those who are interested in obtaining a quote for large size orders are encouraged to contact [email protected]. Customers can also make orders directly at https://micronti.com.
About Beyond Medical
Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The Company, through its subsidiary Micron Technologies, is also manufacturing medical grade face masks.
For further information contact:
Kal Malhi , CEO 604-805-4602
The Company is not making any express or implied claims that its products have the ability to eliminate, cure or contain COVID-19 (or SARS-2 Coronavirus) at this time.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this news release. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.
FORWARD LOOKING STATEMENTS:
This news release includes certain statements that may be deemed “forward-looking statements”. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”,“plans”,“anticipates”,“believes”, “intends”,“estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements.
Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing,and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward- looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.
BEYOND MEDICAL TECHNOLOGIES INC. Suite 915 – 700 West Pender Street Vancouver,BC V6C 1G8 Canada
BEYOND MEDICAL TECHNOLOGIES INC.
Suite 915 – 700 West Pender
Street Vancouver,BC V6C 1G8